BOSTON & MONTREAL, January 31, 2025--enGene Holdings Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage genetic ...

BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with ...

BALTIMORE, Jan. 31, 2025 (GLOBE NEWSWIRE) -- February is National Cancer Prevention Month, and the Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), ...

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva. Despite promising data and market potential, UroGen's low market cap ...

The former Kate Middleton was diagnosed with cancer early in 2024, and much speculation about the state of her health has followed. Catherine, Princess of Wales, has since shared that she ...

Individuals with vitiligo did not display a significantly increased risk for cancer compared with the general population, according to a study.“Traditionally linked to other autoimmune diseases, ...

Discover recent advancements in near-infrared fluorescence imaging that have revolutionised lymph node tracing in cancers ...

Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...

Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...

Sequential gemcitabine docetaxel is increasingly viewed as a valid option for BCG unresponsive non-muscle-invasive bladder cancer (NMIBC).

KRISTOPHER WENTZEL ONCOLOGY Hematologist Oncologist The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate Dr. Kristopher Wentzel leads the ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...